Guilford Pharmaceuticals to Announce Second Quarter 2004 Financial Results on Monday, August 9, 2004

Guilford Pharmaceuticals to Announce Second Quarter 2004
Financial Results on Monday, August 9, 2004 


BALTIMORE, July 19  /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc.
(NASDAQ:GLFD) will announce its second quarter 2004 financial results on
Monday, August 9, 2004 before the opening of the U.S. financial markets. The
company will also host a conference call and live audio webcast at 10:00 a.m.
E.T. following the announcement.  During this call, Guilford's management will
discuss the financial results and other business for the upcoming year.

The press release and live webcast can be accessed by going to the Investor
Relations section of Guilford's website at http://www.guilfordpharm.com/. 
Following the webcast, an archived version of the call will be available until
Monday, August 16, 2004.

To participate in the live conference call, U.S. residents should dial
800-901-5241, international callers 617-786-2963.  The participant passcode is
66836765.

An audio replay of the conference call will be available for 72 hours beginning
at approximately 1:00 p.m. E.T. on August 9, 2004 through 1:00 p.m. August 12,
2004.  To access the replay, U.S. residents should dial 888-286- 8010, (int'l
callers 617-801-6888), passcode 19740997.

Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the
research, development and commercialization of products that target the
hospital market. Presently, Guilford markets two commercial products,
GLIADEL(R) Wafer (polifeprosan 20 with carmustine implant), for the treatment
of brain cancer, and AGGRASTAT(R) Injection (tirofiban hydrochloride), a
glycoprotein GP IIb/IIIa receptor antagonist used for the treatment of acute
coronary syndrome (ACS). Guilford's product pipeline includes a novel
anesthetic, AQUAVAN(R) Injection.  For additional information about GLIADEL(R)
Wafer, please visit http://www.gliadel.com/; and for AGGRASTAT(R) Injection,
please see http://www.aggrastat.com/.

   Contact:  Guilford Pharmaceuticals Inc.
             Stacey Jurchison 410.631.5022
             

DATASOURCE: Guilford Pharmaceuticals Inc.



CONTACT: Stacey Jurchison, Guilford Pharmaceuticals Inc.,

[phone], 



Web site:  http://www.guilfordpharm.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/112882.html

Copyright